KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Zoetis (ZTS) over the last 16 years, with Q4 2025 value amounting to $2.3 billion.

  • Zoetis' Cash & Equivalents rose 1635.63% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 1635.63%. This contributed to the annual value of $2.3 billion for FY2025, which is 1635.63% up from last year.
  • Per Zoetis' latest filing, its Cash & Equivalents stood at $2.3 billion for Q4 2025, which was up 1635.63% from $2.1 billion recorded in Q3 2025.
  • Zoetis' Cash & Equivalents' 5-year high stood at $3.7 billion during Q2 2021, with a 5-year trough of $1.4 billion in Q2 2025.
  • Its 5-year average for Cash & Equivalents is $2.4 billion, with a median of $2.1 billion in 2023.
  • Per our database at Business Quant, Zoetis' Cash & Equivalents soared by 8462.33% in 2021 and then tumbled by 4300.47% in 2023.
  • Zoetis' Cash & Equivalents (Quarter) stood at $3.5 billion in 2021, then rose by 2.75% to $3.6 billion in 2022, then crashed by 43.0% to $2.0 billion in 2023, then fell by 2.65% to $2.0 billion in 2024, then grew by 16.36% to $2.3 billion in 2025.
  • Its Cash & Equivalents was $2.3 billion in Q4 2025, compared to $2.1 billion in Q3 2025 and $1.4 billion in Q2 2025.